TickerFactsScreenerDevelopers

Marker Therapeutics, Inc. (MRKR) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$5.47M2013: -$2.66M2014: -$3.37M2015: -$6.16M2016: -$8.49M2017: -$11.48M2018: -$148.17M2019: -$22.53M2020: -$28.89M2021: -$39.48M2022: -$19.79M2023: -$14.58M2024: -$11.12M2025: -$12.89M-$12.89M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$12.89M-15.9%
2024-$11.12M+23.7%
2023-$14.58M+26.3%
2022-$19.79M+49.9%
2021-$39.48M-36.7%
2020-$28.89M-28.2%
2019-$22.53M+84.8%
2018-$148.17M-1190.7%
2017-$11.48M-35.2%
2016-$8.49M-37.9%
2015-$6.16M-82.7%
2014-$3.37M-26.5%
2013-$2.66M—
2010-$5.47M—